These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34310709)

  • 1. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
    Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
    Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal Cancer Genome Reporter: variant interpretation report for precision oncology.
    Nakken S; Fournous G; Vodák D; Aasheim LB; Myklebost O; Hovig E
    Bioinformatics; 2018 May; 34(10):1778-1780. PubMed ID: 29272339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification.
    Kim J; Naqvi AS; Corbett RJ; Kaufman RS; Vaksman Z; Brown MA; Miller DP; Phul S; Geng Z; Storm PB; Resnick AC; Stewart DR; Rokita JL; Diskin SJ
    Bioinformatics; 2024 Mar; 40(3):. PubMed ID: 38426335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
    AlDubayan SH; Conway JR; Camp SY; Witkowski L; Kofman E; Reardon B; Han S; Moore N; Elmarakeby H; Salari K; Choudhry H; Al-Rubaish AM; Al-Sulaiman AA; Al-Ali AK; Taylor-Weiner A; Van Allen EM
    JAMA; 2020 Nov; 324(19):1957-1969. PubMed ID: 33201204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants.
    Garcia M; Juhos S; Larsson M; Olason PI; Martin M; Eisfeldt J; DiLorenzo S; Sandgren J; Díaz De Ståhl T; Ewels P; Wirta V; Nistér M; Käller M; Nystedt B
    F1000Res; 2020; 9():63. PubMed ID: 32269765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
    He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
    Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VAReporter: variant reporter for cancer research of massive parallel sequencing.
    Huang PJ; Lee CC; Chiu LY; Huang KY; Yeh YM; Yang CY; Chiu CH; Tang P
    BMC Genomics; 2018 May; 19(Suppl 2):86. PubMed ID: 29764369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing actionability and incidental findings of germline variants in two precision oncology trials.
    Ibrahim MB; Adnani Y; Clément GJ; Lacroix L; Loriot Y; Besse B; Massard C; Rouleau E
    Eur J Cancer; 2024 Oct; 210():114256. PubMed ID: 39154486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
    Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
    JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.
    Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB
    Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging significance of secondary germline testing in cancer genomics.
    Mandelker D; Zhang L
    J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes.
    Walsh MF; Ritter DI; Kesserwan C; Sonkin D; Chakravarty D; Chao E; Ghosh R; Kemel Y; Wu G; Lee K; Kulkarni S; Hedges D; Mandelker D; Ceyhan-Birsoy O; Luo M; Drazer M; Zhang L; Offit K; Plon SE
    Hum Mutat; 2018 Nov; 39(11):1542-1552. PubMed ID: 30311369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
    Mandelker D; Donoghue M; Talukdar S; Bandlamudi C; Srinivasan P; Vivek M; Jezdic S; Hanson H; Snape K; Kulkarni A; Hawkes L; Douillard JY; Wallace SE; Rial-Sebbag E; Meric-Bersntam F; George A; Chubb D; Loveday C; Ladanyi M; Berger MF; Taylor BS; Turnbull C
    Ann Oncol; 2019 Aug; 30(8):1221-1231. PubMed ID: 31050713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.
    Lau TTY; May CM; Sefid Dashti ZJ; Swanson L; Starks ER; Parker JDK; Moore RA; Tucker T; Bosdet I; Young SS; Santos JL; Compton K; Heidary N; Hoang L; Schrader KA; Sun S; Kwon JS; Tinker AV; Karsan A
    J Mol Diagn; 2021 Sep; 23(9):1145-1158. PubMed ID: 34197922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward automation of germline variant curation in clinical cancer genetics.
    Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
    Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
    Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
    J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.